TL;DR
A new kind of gene editor is now working inside a human body for the first time. Prime Medicine has given one infusion of a "prime editor" to a person with Wilson disease, an inherited condition in which the body cannot clear copper, and Nature news calls it the first known use of prime editing inside a person. A prime editor rewrites a misspelled DNA letter in place, without cutting both strands of the DNA, which is why researchers see it as a gentler fix. No results exist yet; the first data are due in 2027. But the question the trial asks is the one that matters: can a single shot replace a pill people would otherwise take for the rest of their lives?
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our Odds board on 4 milestones, starting with "Prime Medicine reports first human data for PM577a by 2027"; our labeled speculation on what it adds up to; and every source.



